Treximet (Pernix Therapeutics)
Welcome to the PulseAid listing for the Treximet drug offered from Pernix Therapeutics. This Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC],Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Pernix Therapeutics |
| NON-PROPRIETARY NAME: | Sumatriptan Succinate and Naproxen Sodium |
| SUBSTANCE NAME: | SUMATRIPTAN SUCCINATE; NAPROXEN SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC],Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-05-14 |
| END MARKETING DATE: | 0000-00-00 |
Treximet HUMAN PRESCRIPTION DRUG Details:
| Item Description | Treximet from Pernix Therapeutics |
| LABELER NAME: | Pernix Therapeutics |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 85; 500(mg/1; mg/1) |
| START MARKETING DATE: | 2015-05-14 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 65224-850_d653af2d-0d84-471c-b996-8cbd18b29ccc |
| PRODUCT NDC: | 65224-850 |
| APPLICATION NUMBER: | NDA021926 |
Other SUMATRIPTAN SUCCINATE; NAPROXEN SODIUM Pharmaceutical Manufacturers / Labelers:
